The genome editing revolution

AM Khalil - Journal of genetic engineering and biotechnology, 2020 - Elsevier
Background Development of efficient strategies has always been one of the great
perspectives for biotechnologists. During the last decade, genome editing of different …

[HTML][HTML] Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases

DR Rodríguez-Rodríguez… - International …, 2019 - spandidos-publications.com
Genome editing reemerged in 2012 with the development of CRISPR/Cas9 technology,
which is a genetic manipulation tool derived from the defense system of certain bacteria …

Clinical applications of CRISPR‐based genome editing and diagnostics

DV Foss, ML Hochstrasser, RC Wilson - Transfusion, 2019 - Wiley Online Library
Clustered regularly interspaced short palindromic repeats (CRISPR)‐driven genome editing
has rapidly transformed preclinical biomedical research by eliminating the underlying …

[HTML][HTML] An update on the application of CRISPR technology in clinical practice

F Morshedzadeh, M Ghanei, M Lotfi, M Ghasemi… - Molecular …, 2024 - Springer
The CRISPR/Cas system, an innovative gene-editing tool, is emerging as a promising
technique for genome modifications. This straightforward technique was created based on …

[HTML][HTML] CRISPR/Cas9: the Jedi against the dark empire of diseases

S Khan, MS Mahmood, SU Rahman, H Zafar… - Journal of biomedical …, 2018 - Springer
Abstract Advances in Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR
associated system (CRISPR/Cas9) has dramatically reshaped our ability to edit genomes …

[HTML][HTML] Recent advances in gene therapy for hemophilia: projecting the perspectives

N Chernyi, D Gavrilova, M Saruhanyan… - Biomolecules, 2024 - mdpi.com
One of the well-known X-linked genetic disorders is hemophilia, which could be hemophilia
A as a result of a mutation in the F8 (factor VIII) gene or hemophilia B as a result of a …

Exosomes for CRISPR-Cas9 delivery: the cutting edge in genome editing

C Aslan, NM Zolbanin, F Faraji, R Jafari - Molecular Biotechnology, 2023 - Springer
Gene mutation correction was challenging until the discovery of clustered regularly
interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein (Cas) …

[HTML][HTML] Novel genetic therapeutic approaches for modulating the severity of β‑thalassemia

F Amjad, T Fatima, T Fayyaz… - Biomedical …, 2020 - spandidos-publications.com
Thalassemia is a genetic haematological disorder that arises due to defects in the α and β‑
globin genes. Worldwide, 0.3‑0.4 million children are born with haemoglobinopathies per …

[HTML][HTML] CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review

H Babačić, A Mehta, O Merkel, B Schoser - PloS one, 2019 - journals.plos.org
Introduction The system of clustered regularly interspaced short palindromic repeats
(CRISPR) and CRISPR-associated proteins (cas) is a new technology that allows easier …

Machine learning meets cancer

EV Varlamova, MA Butakova, VV Semyonova… - Cancers, 2024 - mdpi.com
Simple Summary This review examines the latest technologies using machine learning (ML)
methods, including the use of convolutional neural networks, decision trees, and generative …